Friday, September 26, 2014

Lovego Weekly report-Respiratory Failure

LoveGo, Go Along With Love!
Your Second Doctor

Weekly report

Respiratory Failure

Respiratory failure is a disease of the lungs. It is inadequate gas exchange by the respiratory system, with the result that levels of arterial oxygen, carbon dioxide or both cannot be maintained within their normal ranges.

In practice, it diveides into Type I (Hypoxemic respiratory failure) and Type II ( Hypercapnic respiratory failure) ;

In clinical,it clarified as Acute Respiratory Failure and chronic Acute Respiratory Failure.
               











 In practice

 

Hypoxemic respiratory failure

(Type I)


Characterized by an arterial oxygen tension (Pa O2) lower than 60 mm Hg with a normal or low arterial carbon dioxide tension (Pa CO2)

=>Low oxygen, and normal or low carbon dioxide levels.


 

Cardiogenic or noncardiogenic pulmonary edema, pneumonia, and pulmonary hemorrhage

   Hypercapnic respiratory failure

(Type II)

Characterized by a PaCO2 higher than 50 mm Hg

=>Low oxygen, with high carbon dioxide.


Asthma and chronic obstructive pulmonary disease [COPD]

Type I respiratory failure occurs because of damage to lung tissue. This lung damage prevents adequate oxygenation of the blood (hypoxaemia); however, the remaining normal lung is still sufficient to excrete the carbon dioxide being produced by tissue metabolism. This is possible because less functioning lung tissue is required for carbon dioxide excretion than is needed for oxygenation of the blood.

Type II respiratory failure is also known as ‘ventilatory failure’. It occurs when alveolar ventilation is insufficient to excrete the carbon dioxide being produced. Inadequate ventilation is due to reduced ventilatory effort, or inability to overcome increased resistance to ventilation – it affects the lung as a whole, and thus carbon dioxide accumulates. Complications include: damage to vital organs due to hypoxaemia, CNS depression due to increased carbon dioxide levels, respiratory acidosis (carbon dioxide retention). This is ultimately fatal unless treated. Complications due to treatment may also occur.

Respiratory failure is accompanied by a number of symptoms including:
Bluish coloration of the lips or fingernails
Confusion or loss of consciousness
Fainting or change in level of consciousness or lethargy
Fatigue
Irregular heart rate (arrhythmia)
Rapid breathing (tachypnea) or shortness of breath
Serious symptoms that might indicate a life-threatening condition


One of the main goals of treating respiratory failure is to get oxygen to your lungs and other organs and remove carbon dioxide from your body. Another goal is to treat the underlying cause of the condition.
Multiple options are available for the treatment of respiratory failure. Examples include:
Antibiotics for respiratory infections
Bilevel positive airway pressure (BiPAP)
Bronchodilators, including anticholinergics, such as tiotropium (Spiriva), or beta agonists, such as albuterol (Proventil)
Continuous positive airway pressure (CPAP)
Inhaled steroid medications to decrease inflammation
Lung transplant, in rare cases
Mechanical ventilation, if oxygen therapy if not sufficient to increase blood oxygen levels
Oxygen therapy to increase blood oxygen levels
Tracheostomy, a hole made in the front of the neck to help you breathe




Any Questions when you use LoveGo POC, kindly contact us

Email:
service@oxygencare.cn Tel: 400 6677 247/075523733851






Lovego Service
Toll free: 400-6677-247
Tel:86-0755-23733851
Add: Building B, LC Hi-tech Park, Longhua District, Shenzhen, China

Friday, September 19, 2014

Lovego Weekly report-Do you know what’s your FEV1.

LoveGo, Go Along With Love!
Your Second Doctor

Weekly report

Do you know what’s your FEV1 ?





FEV1 (Forced Expiratory Volume in 1 second) is measured by spirometry. It plays an important role in chronic obstructive pulmonary disease (COPD).It measures the volume of air, in litres, exhaled during the first second of a forceful exhalation.

The number used (FEV1) is a percent of the average expected of someone of your height, age, sex and race. It is expressed as a percent of predicted. Any number over 80% is considered normal

The testing is done in the doctor’s office using a machine called a spirometer. This handheld device measures your lung function and records the results which are also displayed on a graph. The doctor will ask you to take a deep breath and then blow out into the mouthpiece on the spirometer as hard and fast as you can. It will measure the total amount that were able to exhale which is the forced vital capacity (FVC) as well as how much was exhaled in the first second, which is the forced expiratory volume in 1 second (FEV1). Your FEV1 is also influenced by other factors including your age, sex, height, and ethnicity. The FEV1 is calculated as a percentage of the FVC (FEV1/FVC).

Just as that percentage was able to confirm a diagnosis of COPD, it will also let your doctor know how the disease is progressing.

COPD Progression




STAGE I





mild


Often minimal shortness of breath with or without cough and/or sputum. Usually goes unrecognized that lung function is abnormal



> 80% of predicted




STAGE II




moderate

Often moderate or severe shortness of breath on exertion, with or without cough, sputum or dyspnea. Often the first stage at which medical attention is sought due to chronic respiratory symptoms or an exacerbation



50-80% of predicted





STAGE III





severe


more severe shortness of breath, with or without cough, sputum or dyspnea – often with repeated exacerbations which usually impact quality of life, reduced exercise capacity, fatigue



30-50% of predicted



STAGE IV



very severe

appreciably impaired quality of life due to shortness of breath – possible exacerbations which may even be life threatening at times



Less than 30% of predicted


How Spirometry Assists in COPD Treatment

Regular use of Spirometry for progression tracking is crucial when it comes to COPD treatment. Each stage comes with its own unique issues and understanding what stage your disease is at allows your doctor to recommend and prescribe the best possible treatment for your stage of disease.

While staging assists in the creation of standard treatments, your doctor will take your spirometer results into consideration along with other factors to create a treatment that is personalized to you. Factors such as other comorbidities that may affect your lung capacity further like cardiovascular disease will be a consideration, as will your physical condition when it comes to rehabilitation therapy such as exercise.

Your doctor will schedule regular tests and use the spirometer results to make adjustments to your treatment as needed. This not only includes medications and even recommendation for surgery in some cases, but also lifestyle changes and rehabilitation programs to help improve your symptoms, slow progression, and improve your quality of life.

Spirometry, along with assisting in staging and treatment recommendations, also lets your doctor periodically check whether or not your treatment is working. The results of your tests can tell the doctor whether your lung capacity is stable, improving, or decreasing so that adjustments to treatment can be made.

This simple, inexpensive, and non-invasive test can help a COPD patient through all the various stages of treatment.



Any Questions when you use LoveGo POC, kindly contact us
Email: service@oxygencare.cn Tel: 400 6677 247/075523733851





 Lovego Service
Toll free: 400-6677-247
Tel:86-0755-23733851
Add: Building B, LC Hi-tech Park, Longhua District, Shenzhen, China

Thursday, September 18, 2014

Combo Therapy Best for COPD: Study

Combo Therapy Best for COPD: Study

Researchers found two-drug regimen cut death, hospitalization rates for the respiratory disease

By Dennis Thompson
HealthDay Reporter
TUESDAY, Sept. 16, 2014 (HealthDay News) -- A combination drug therapy aimed at opening the airways and reducing inflammation appears to be the best treatment for older adults with chronic obstructive pulmonary disease (COPD), especially those with asthma, a new study finds.
COPD patients who received a combination of long-acting beta agonists and inhaled corticosteroids were less likely to die or require hospitalization because of their breathing disorder, compared to people receiving only one of the two medications, Canadian researchers report.
The study findings were published in the Sept. 17 issue of the Journal of the American Medical Association.
The findings go against the official guidelines for treating COPD, but actually support what most chest physicians are doing in the clinic, said lead author Dr. Andrea Gershon, a scientist with the Sunnybrook Health Sciences Center and the Institute for Clinical Evaluative Sciences in Toronto.
Current treatment guidelines call for COPD patients to first receive a long-acting beta agonist, which relaxes the muscles of the airways and widens them, resulting in easier breathing. If that doesn't work, physicians then can add an inhaled corticosteroid, which reduces inflammation.
"We found the combination therapy appeared to be more effective, and we found that a lot of people are being started on this combination therapy straight away," Gershon said. "Maybe doctors have had an intuitive sense of these benefits, or maybe drug companies had really good marketing."
Further, researchers found that the combination therapy did not compound a person's risk of side effects from either drug, most notably osteoporosis and pneumonia.
"I suspect when doctors read this, they are going to skip that first step and go straight to combination drug therapy," said Dr. Norman Edelman, senior medical advisor to the American Lung Association.
COPD is the third leading cause of death worldwide, researchers said in background information. The disease makes it progressively more difficult for patients to draw a breath, with symptoms slowly worsening over time.
The study involved government health data in Ontario on almost 12,000 people with COPD between 2003 and 2011, including 8,712 patients newly placed on combination therapy and 3,160 new users of long-acting beta agonists.
The records involved real-world situations, with doctors treating patients according to their best judgment, Edelman noted.
"It's one thing to perform a drug trial and select patients very carefully and see how your drugs perform, and another to look back and see how people have done in the real world with real doctors," he said.
Researchers found that about 37.3 percent of people died while using beta agonists alone, compared with 36.4 percent of people using the combination therapy.
Similar results occurred for hospitalizations caused by COPD -- about 30.1 percent for people on the single drug, versus 27.8 percent for people taking the combination.
Overall, the use of combination therapy reduced risk of death or hospitalization by 3.7 percent, compared with beta agonists alone, the study found.
The greatest difference was among COPD patients who had also been diagnosed with asthma. Overall, those on combination therapy had a 6.5 percent reduced risk of either death or hospitalization compared with those taking a single drug.
The researchers noted, however, that the combination therapy appeared to be less effective for people who are using inhaled long-acting anticholinergic medication, a different class of COPD medication that works by inhibiting the transmission of certain nerve impulses to help reverse airway resistance.
Those who received the combination therapy and had never taken a long-acting anticholinergic had an 8.4 percent reduced risk of death or hospitalization.
The findings are likely to reassure most physicians that they already are doing the right thing, given that many already are prescribing combination therapy, said Dr. Darcy Marciniuk, the immediate past president of the American College of Chest Physicians and head of the division of respirology, critical care and sleep medicine at the University of Saskatchewan in Saskatoon, Canada.
Before paring down their patient sample for research purposes, the Canadian researchers determined that doctors had started 34,289 new patients on combination therapy during the period in question, compared with 3,258 who were prescribed beta agonists alone.
"About 10 times more people were started on combination therapy than were started on the single therapy," Marciniuk said. "That speaks for itself."

Thursday, September 11, 2014

Weekly report 12nd September-Share the story of Greg Miller---- Who has rich experience in COPD & Emphysema and help his mother completely recovery from the disease

LoveGo, Go Along With Love!
Your Second Doctor

Weekly report

Share the story of Greg Miller----

Who has rich experience in  COPD & Emphysema and help his mother completely recovery from the disease



"When my mother was first diagnosed with emphysema I began researching the disease online. Every search eventually led back to a pharmaceutical web site telling the bad news, that the disease was terminal and the 
only hope was taking their medications and slowing its progress.

After two and a half years of my mother taking all the prescribed medications and doing all of the prescribed emphysema treatments she was noticeably worse. The puzzling aspect to me was that she had not smoked during that time. I understood that her emphysema was caused by smoking cigarettes but I also knew from engineering school that once something is taken out of the equation it is no longer a factor in the outcome. Smoking had been taken out of the equation so I knew it could not be causing her deteriorating condition.

I asked the doctor why her emphysema was getting worse so long after she had quit smoking. He replied, at first, with some medical rhetoric about thealpha-1-antitrypsin deficiencystating that it "could be thealpha-1-antitrypsin deficiency.

By this time I had completed more than 3,000 hours of research on emphysema and knew that this deficiency was a genetic disorder that generally produced visible symptoms in the late 20's or early 30's. When I let him know that I knew of this deficiency and knew this was not my mother's problem. I told him we both knew my mother's problem was a result of more than 30 years of smoking cigarettes. He then looked me right in the eye and told me that the truth was, they simply did not know why emphysema continued progressing long after smoking cessation. It was a mystery.


I decided right then and there I would continue researching emphysema from every aspect and perspective until I either solved the mystery or my mother took her last breath. One thing I was sure of, the pharmaceutical medications and treatments only masked symptoms. They provided no lasting improvement or healing. I later found out when my mother was in End Stage Emphysema that they one-by-one stopped working and would not even provide the temporary relief they once had.

Luckily, through the grace of God and many hours of prayer, God led me to the answers. I subsequently developed six general protocols, the specifics of which, completely reversed my mother's emphysema. By then I had completed more than 6500 hours of research besides graduate courses in Pathology, Pulmonary Physiology, Renal Physiology, Cardiac Physiology, Histology, Human Genetics and Human Anatomy Dissection. I read countless books during that time from doctors all over the world. Medical doctors, Osteopaths, Chiropractors, Naturopaths and Ph.D.'s were among the authors.



Pls visit the website

http://www.optimalhealthprotocols.com

http://www.emphysema-treatments.com

Join the facebook group

https://www.facebook.com/groups/optimalhealthprotocols


We’ll update more information about Mr Miller's way for treatment in the blog




Any Questions when you use LoveGo POC, kindly contact us

Email: service@oxygencare.cn Tel: 400 6677 247/075523733851





Lovego Service
Toll free: 400-6677-247
Tel:86-0755-23733851
Add: Building B, LC Hi-tech Park, Longhua District, Shenzhen, China


Thursday, September 4, 2014

Weekly report 5th September -Several Questions to Ask Your Doctor About Your COPD Treatment



LoveGo, Go Along With Love!
Your Second Doctor


Weekly report

Several Questions to Ask Your Doctor About Your COPD Treatment


If you’ve been diagnosed with Chronic Obstructive Pulmonary Disease (COPD), you likely know the difficulties that come with being unable to properly process oxygen through your lungs. Once your physician has diagnosed you, you may have several questions about the progression of the disease, as well as the treatments they recommend. Here are a few questions you should ask your doctor before beginning a treatment program.


1. What can I expect if I stop smoking?


Smoking is the top cause of COPD, with some estimates stating it causes as much as 90 percent of all COPD cases. When you stop smoking, within a few hours, the amount of carbon monoxide in your blood is cut in half. If you’ve ever had surgery, you were probably told to stop smoking at least eight hours before. This reduces the carbon monoxide in your blood to a level that is safe for surgery.

A few weeks after you stop smoking, your lungs will begin repairing themselves. Within three months, you’ll likely feel a marked improvement in your ability to breathe. In just one year, the cilia in your lungs will begin to move mucus more smoothly again, resulting in a reduction of symptoms like chronic coughing and shortness of breath. By your tenth smoke-free year, your risk of lung cancer will be cut in half.

For women, this progress is even faster, according to research conducted by the National Heart Lung and Blood Institute. While former smokers will always have a risk of COPD, that risk is increased by the number of years you smoke. Once you’ve been diagnosed with COPD, there’s no cure, although lung repair can help slow the progression of the disease. Continuing to smoke will only exacerbate the disease, potentially leading to such dangerous symptoms as pneumonia and infections.

2. What side effects can I expect from my medication?

You’ve probably seen the five-minute disclaimers at the end of pharmaceutical commercials. One of the biggest concerns you could have about any treatment is that it might cause damage to other, healthy parts of your body. Check with your physician before beginning any treatment program to make sure that you know all the dangers associated with it.


3. Are there any changes I can make to help my condition?

Your overall health will likely have a very positive impact on your reaction to COPD symptoms. While diet and exercise won’t cure COPD, they can help slow the disease, as well as help you breathe better and feel less discomfort. Your doctor can also explain to you the benefits of drinking water and beginning anexercise program that helps relieve COPD symptoms.

4. Besides smoking, what other factors can aggravate my COPD?

Some patients are concerned about allergens like pets, dust, and other environmental factors. If you have extreme COPD symptoms, your physician may recommend wearing a mask to cut down on the pollutants you inhale. Explain the specifics of your lifestyle to your doctor to see if they can make any recommendations about changes to your environment that will help you breathe better.

Your doctor will likely also recommend that you stay away from people who have infections and contagious illnesses. If you have COPD, even a minor illness can weaken your immune system, putting you at greater risk for problems. In fact, staying healthy in general can help ensure longevity. A healthy diet that includes vitamins that strengthen the immune system can help you fight off viruses that come your way.

5. Do I need any shots or vaccinations?

Some COPD patients choose to get a pneumonia vaccine to lessen their risk of getting the infection. As pneumonia can deteriorate lung health and lead to a weakened system and eventual overall health decline, many people with COPD have found security in getting a pneumonia vaccine, which protects against a couple dozen strains.

It is recommended that you get an annual flu shot, which is readily available at many drug stores and doctors’ offices, if you have COPD. In fact, the influenza vaccine is recommended for most people, no matter their health conditions. Like pneumonia, the flu can weaken a COPD patient’s lungs and immune system, leading to problems that healthy patients wouldn’t face.

If you’ve been diagnosed with COPD, likely you have many questions. To prepare for your next appointment, keep a notepad and write down any questions that come to mind and pose those questions to your doctor the next time you get a chance. Working with your doctor, you can get a handle on this disease and begin to fight it.



                                                     Written by Stephanie Faris
                                                     Medically Reviewed by George Krucik, MD


Any Questions when you use LoveGo POC, kindly contact us
Email: service@oxygencare.cn   Tel: 400 6677 247/075523733851






Lovego Service
Toll free: 400-6677-247
Tel:86-0755-23733851
Add: Building B, LC Hi-tech Park, Longhua District, Shenzhen, China




Lovego video-Legend


LoveGo video



Thanks for watching.Hope It will be helpful for you

Lovego video-Introduces how the machine works



Lovego Video


This video is not intended to be used for diagnosis of any medical condition. Patients seeking diagnosis should consult a physician. it is important for you to carefully read the owner's manual before operating. We lovego will reserve all the right for the final explanation.


Lovego is the world newest Generation POC, Providing  5LPM
continuous oxygen at 93% purity. The Lovego POC brings you a whole new world with really freedom to do the things you like with the people you love participate in the activities you want to. Such as fishing,  playing in park, in the sea sides and so on.
Lovego, go along with love!


Welcome to Lovego Media, My name is peter liu, your friend in China. Today we gonna talk about the world newest Lovego medical POC.  Purchasing the lovego, it will arrive at your doorstep in a box ,simply open the box, then you can see: the portable bag, Lithium battery, car inverter, battery charger, the nasal canula, headstyle  cannula, then the small humidifier cup.

Let’s take out the machine and I will show you how the machine works. At first, put the humidifier cup here, and connect the pipe.
Then, take the electric code, let’s plug it into the AC power such at home, hotel,
you see like this, very easy
Then you can see the machine screen turn bright, but it doesn’t work now.
Look at this number,it tells you how many hours the machine has worked.
Then press on
Now, lovego is providing continuously oxygen 24/7 hours and without stop
If you want to set the work time while sleep, you can press time plus, you see, thirty minutes, 1 hour, 2 hours, and till 8 hours.
If you want to reduce, just press time minus.
Look at the flow meter, lovego is the most powerful POC that can provide continuously flow at any rate from 0-5LPM,you can turn right and turn left to adjust the flow meter and get the oxygen you need.


So what the difference between continuously flow and pulse flow ? Followed you will know.

Let put the pure water into the humidifier cup, and then set it here, connect the pipe, turn on the machine.
Now you can see the continuously bubbles, and not like this


So what’s purity of lovego you are getting ? Look at the oxygen purity test machine, it is servemax made in UK.
Let’s press on, now the machine is working, and adjust to 1LPM,
you see,
The oxygen purity is increasing.
Ok, you can see the purity reaches above 90%, it can reach 93% within 10 minutes.
You can see the real purity of lovego


Now turn off the machine, I’ll introduce the powerful function anion, press the anion button, the anion button will turn green and work, It is a small air purifier to fresh your surroundings, remove the dust, smoke, and kill the bacteria.
It also can be used when producing the oxygen. That means, lovego not only give freedom to us, but also provide healthy air to our families.
Lovego will replace the home large concentrator, oxygen cylinder, oxygen purifier.


Ok, next I will show you how lovego works with the battery.
Connect the battery with car inverter, like this, and then put the electric code with car inverter, just press on, it will be ok.
If you want to bring the machine outside, you can put the battery and car inverter into the portable bag.
Ok, lovego, let’s go along with love.


Ok, next I will show you how the lovego works in the car
Let’s take the machine and car inverter on the car, and plug the car inverter into the cigarette lighter, like this.
Then connect the electric code with car inverter, press on, it will be ok.



With lovego, you can do what you want, when you want, and no worry about of running out of oxygen.


Monday, September 1, 2014

What is COPD?



COPD is a lung disease that over time makes it hard to breathe. COPD ( Chronic Obstructive  Pulmonary Disease) includes chronic bronchitis and emphysema. Obstruction in COPD means that the flow of air in and out of the lungs is less than it should  be.  When  that happens less oxygen gets into the body tissues and it becomes harder to get rid of carbon dioxide  
which is the waste gas. As the disease gets worse, it is harder to remain active due to shortness of  
breath. Most importantly, COPD can be prevented and can be treated.
People with COPD have difficulty breathing. In the early stage of COPD, they may feel breathless during physical activity. Eventually, they have trouble breathing even at rest.
The lungs’ airways are called bronchi, or “branches.” They divide and spread throughout the lung and end in tiny sacs. In someone with normal lungs, these sacs inflate upon the inhale and deflate upon the exhale. In people with COPD, the sacs don't work properly because they are damaged (this condition is also known as emphysema) or the bronchi become inflamed (chronic bronchitis).

With chronic bronchitis the lining of the breathing tubes become swollen and produces a lot of mucus 
that gets coughed up. With emphysema the walls of the air sacs in the lung are broken down and the air 
spaces get larger and air gets trapped. Some people have both chronic bronchitis and emphysema, so we 
now prefer to call the disease COPD.